| Reference |
|---|
Zhou P, Song G, Liu H, Yuan M, He W, Beutler N, et al. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity. 2023;56:669-686.e7 pubmed publisher |
He W, Yuan M, Callaghan S, Musharrafieh R, Song G, Silva M, et al. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Sci Transl Med. 2022;14:eabl9605 pubmed publisher |
Hossain M, Anasti K, Watts B, Cronin K, Derking R, Groschel B, et al. B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates. Cell Rep. 2022;39:111021 pubmed publisher |
Gonzales S, Clarke K, Batugedara G, Garza R, Braddom A, Reyes R, et al. A Molecular Analysis of Memory B Cell and Antibody Responses Against Plasmodium falciparum Merozoite Surface Protein 1 in Children and Adults From Uganda. Front Immunol. 2022;13:809264 pubmed publisher |
Shin J, Par Young J, Unlu S, McNamara A, Park H, Shin M, et al. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency. J Clin Immunol. 2022;42:1137-1150 pubmed publisher |
He W, Musharrafieh R, Song G, Dueker K, Tse L, Martinez D, et al. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses. Nat Immunol. 2022;23:960-970 pubmed publisher |
Seow J, Graham C, Hallett S, Lechmere T, Maguire T, Huettner I, et al. ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants. Cell Rep. 2022;39:110757 pubmed publisher |
Tortorici M, Czudnochowski N, Starr T, Marzi R, Walls A, Zatta F, et al. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021;597:103-108 pubmed publisher |
Starr T, Czudnochowski N, Liu Z, Zatta F, Park Y, Addetia A, et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021;597:97-102 pubmed publisher |
Graham C, Seow J, Huettner I, Khan H, Kouphou N, Acors S, et al. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity. 2021;54:1276-1289.e6 pubmed publisher |
Tian L, Elsheikh E, Patrone P, Kearsley A, Gaigalas A, Inwood S, et al. Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19. Int J Mol Sci. 2021;22: pubmed publisher |
Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher |
Zhao F, Joyce C, Burns A, Nogal B, Cottrell C, Ramos A, et al. Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques. Cell Rep. 2020;32:108122 pubmed publisher |
Choi J, Phelan J, Wright G, Häupl B, Huang D, Shaffer A, et al. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14. Proc Natl Acad Sci U S A. 2020;117:6092-6102 pubmed publisher |
Singh M, Jackson K, Wang J, Schofield P, Field M, Koppstein D, et al. Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. Cell. 2020;180:878-894.e19 pubmed publisher |
Martin G, Pace M, Thornhill J, Phetsouphanh C, Meyerowitz J, Gossez M, et al. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA. Front Immunol. 2018;9:928 pubmed publisher |
Yeung Y, Foletti D, Deng X, Abdiche Y, Strop P, Glanville J, et al. Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire. Nat Commun. 2016;7:13376 pubmed publisher |
Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher |
Pontarini E, Fabris M, Quartuccio L, Cappeletti M, Calcaterra F, Roberto A, et al. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome. Rheumatology (Oxford). 2015;54:1429-34 pubmed publisher |
Upton D, Unniraman S. Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes. J Vis Exp. 2011;:e3573 pubmed publisher |
